Economy

Janney Montgomery Scott Reiterates "Buy" Rating for Agile Therapeutics, Inc. (AGRX)

Janney Montgomery Scott Reiterates

Agile Therapeutics has $10 highest and $8 lowest target.

Agile Therapeutics, Inc. (AGRX) is expected to post revenue of $0 in the current quarter, according to consensus of 5 analysts. Following the purchase, the insider now owns 60,583 shares of the company's stock, valued at approximately $202,953.05. The company had a trading volume of 263,653 shares. Proquest Associates Iv Llc owns $17.72 million in Agile Therapeutics, Inc., which represents roughly 14.13% of the company's market cap and approximately 21.87% of the institutional ownership. Tower Rech Capital (Trc) has 0% invested in Agile Therapeutics Inc (NASDAQ:AGRX) for 1,415 shares. J Goldman & Limited Partnership holds 0.01% in Agile Therapeutics Inc (NASDAQ:AGRX) or 36,000 shares. The company was maintained on Monday, August 15 by FinnCap. Royal Bank Of Canada now has an outperform rating on the stock. It has underperformed by 65.41% the S&P500.The move comes after 6 months positive chart setup for the $124.61M company. The average is taken over a specific period of time, like 10 days, 20 minutes, 30 weeks, or any time period the trader chooses. The firm now has a $13.00 price objective on the specialty pharmaceutical company's stock. More interesting news about Agile Therapeutics Inc (NASDAQ:AGRX) were released by: Globenewswire.com and their article: "Agile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare ..." published on September 14, 2017 as well as Seekingalpha.com's news article titled: "Agile Therapeutics: No Reason For The FDA To Approve Another Inferior Patch" with publication date: May 16, 2017. Agile Therapeutics had 8 analyst reports since December 30, 2015 according to SRatingsIntel. Finally, Noble Financial restated a "buy" rating on shares of Agile Therapeutics in a research report on Wednesday, June 14th.

Investors sentiment decreased to 0.61 in 2016 Q4. Its up 0.72, from 1.41 in 2016Q3. It improved, as 1 investors sold AGRX shares while 14 reduced holdings. 9 funds opened positions while 23 raised stakes. The stock presently has an average rating of "Buy" and an average price target of $9.08. The stock climbed 0.53 percent over the past quarter, while surged 39.78 percent over the past six months. Granahan Ma reported 99,225 shares. RBC Capital Markets has "Buy" rating and $800 target. Nelson Van Denburg Campbell Wealth Mngmt Grp Ltd Liability reported 0% of its portfolio in M.D.C. Holdings, Inc. The stock has "Buy" rating by Noble Financial on Tuesday, June 27. The company reported revenue of $0 in the same period previous year. The rating was maintained by Noble Financial with "Buy" on Friday, July 28. The number of shares now owned by investors are 33.34 mln. The legal version of this news story can be read at https://weekherald.com/2017/09/15/agile-therapeutics-inc-agrx-sees-large-volume-increase-following-analyst-upgrade.html. The rating was maintained by Noble Financial on Friday, July 28 with "Buy". Morgan Stanley stated it has 0% in Agile Therapeutics Inc (NASDAQ:AGRX). Northern Trust Corporation invested in 0% or 141,928 shares. Agile Therapeutics Inc (NDAQ:AGRX) has declined 48.71% since September 14, 2016 and is downtrending. 2,700 were accumulated by Cubist Systematic Strategies Llc.

The Sweden-based Investor has invested 1.46% in Agile Therapeutics Inc (NASDAQ:AGRX). The company has market cap of $119.49 million. It now has negative earnings.

Agile Therapeutics (NASDAQ:AGRX) last announced its quarterly earnings data on Friday, July 28th. Our lead product candidate, Twirla, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is a once-weekly prescription contraceptive patch that recently completed Phase 3 trials. During the same quarter a year ago, the company earned ($0.29) EPS. Highland Capital Management LP now owns 142,724 shares of the specialty pharmaceutical company's stock valued at $813,000 after buying an additional 118,551 shares during the period. Twirla is based on our proprietary transdermal patch technology, called Skinfusion, which is created to provide advantages over now available patches and is meant to optimize patch adhesion and patient wearability.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Like this

Latest


16 September 2017
Leon Osman: 'Everton have failed to replace Romelu Lukaku'
Koeman has showered praise on the Belgian, saying that "he is a great finisher", who is fast, strong, and risky in the box. Manchester United legend Rio Ferdinand has urged Romelu Lukaku to study the game of Chelsea icon Didier Drogba .

16 September 2017
Top Senate Republican on tax says Big Six won't dictate tax reform
The approval process for the biggest Tax Cut & Tax Reform package in the history of our country will soon begin. He said he would love to have the Democrats working with the GOP "but we're going to do it no matter what".

16 September 2017
(EXR) With Shares Trading up at $78.37 Extra Space Storage Inc. Provides…
Reinhart Partners Inc decreased Trueblue Inc Com (NYSE:TBI) stake by 58,050 shares to 74,672 valued at $1.84 million in 2016Q4. Aqr Management Limited Liability owns 39,810 shares for 0% of their portfolio. (NYSE:EXR) rating on Friday, September 4.

16 September 2017
Complaint filed in Hollywood nursing home deaths
Broward officials said that the nursing home was in compliance with state and federal rules that require an evacuation plan. But they didn't anticipate they would still have to fight the intense heat with fans and portable air conditioner units.

16 September 2017
(VAR) Shares Trading down at $107.68 Varian Holds First Clinical Workshop at…
Since March 17, 2017, it had 0 buys, and 9 selling transactions for $10.10 million activity. 862 Varian Medical Systems, Inc. On Thursday, June 8 the insider LARET MARK R sold $147,761. (NYSE:VAR) to report earnings on October, 25 after the close.

16 September 2017
Anti-doping group wants Winter Games ban of Russian leaders
IOC President Thomas Bach said: "Congratulations to Mr Ban on his election as Chair of the IOC Ethics Commission". Reedie called the criticisms "unhelpful and backward looking".

16 September 2017
Manchester United's Lukaku: Belgian striker reaches 150 club career goals
Lukaku, who was Everton's top scorer last season, joined Manchester United this summer, on a big money transfer. On the England star, Blind added: "He went to play more [at Everton] than he did [at United]".

16 September 2017
Canadian PM concerned over Rohingya crisis
McCain has sought to remove language from a defense spending bill detailing expanded military cooperation with Myanmar.

16 September 2017
ANSYS, Inc. (NASDAQ:ANSS) Sees Unusual Trading Volume in Its Shares
DINARDO SHEILA S also sold $319,080 worth of ANSYS, Inc. (NASDAQ:ANSS) has "Buy" rating given on Monday, August 28 by Robert W. The software maker reported $0.99 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.92 by $0.07.

16 September 2017
Qualcomm Tease Apple: Android Always First To New Features
These fall in direct competition with Apple's iPhone 8 , which will be powered by the latest A11 Fusion chipset, stay tuned. They're technologies supported by the Galaxy S8, Galaxy Note 8, Moto Z2 Force, HTC U11, LG V30, and Sony Xperia XZ1.



Recommended